Shuaifei Wang

1.8k citations
27 papers · 1.5k indexed · 1 hit paper · h-index 13
Topics
Nanoplatforms for cancer theranostics (6 papers)Advanced Nanomaterials in Catalysis (5 papers)Inorganic Fluorides and Related Compounds (3 papers)

In The Last Decade

Shuaifei Wang

27 papers receiving 1.5k citations

Hit Papers

Arginine-Rich Manganese Silicate Nanobubbles as a Ferropt...20182026202020232018100200300

Peers

Shuaifei Wang
Comparison fields: 5 of 116
  • Biomedical Engineering 870
  • Materials Chemistry 572
  • Biomaterials 381
  • Molecular Biology 293
  • Pulmonary and Respiratory Medicine 243
Replace Yong Kang with:
Yong Kang China
Chieh‐Cheng Huang Taiwan
Chuanhui Song China
Zifei Zhou China
Weipeng Li Taiwan
Yajun Weng China
Yun Chang China
Daquan Wang China
Tian Huang China
Shuaifei Wang relative to Yong Kang China Yong Kang's profile →
Citations per field
00.5×3.7×
Yong Kang · 1×
Citations per year

Countries citing papers authored by Shuaifei Wang

Since Specialization
Citations

This map shows the geographic impact of Shuaifei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuaifei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuaifei Wang more than expected).

Fields of papers citing papers by Shuaifei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuaifei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuaifei Wang. The network helps show where Shuaifei Wang may publish in the future.

Co-authorship network of co-authors of Shuaifei Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Shuaifei Wang. A scholar is included among the top collaborators of Shuaifei Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuaifei Wang. Shuaifei Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 5
3 12
4 5
5 2
6 4
7 4
8 3
9 17
10 5
11 16
12 57
13 55
14 7
15 116
16 19
17 285
18 112
19 156
20 138

About Shuaifei Wang

Shuaifei Wang is a scholar working on Pharmaceutical Science, Rehabilitation and Inorganic Chemistry, having authored 27 papers that have together received 1.5k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (6 papers), Advanced Nanomaterials in Catalysis (5 papers) and Inorganic Fluorides and Related Compounds (3 papers). The work is most often cited by research in Biomaterials (381 citations), Biomedical Engineering (870 citations) and Rehabilitation (119 citations). Shuaifei Wang has collaborated with scholars based in China, South Korea and United States. Frequent co-authors include Daishun Ling, Fangyuan Li, Taeghwan Hyeon, Haibin Wu, Hongwei Liao, Jianqing Gao, Jiahe Wu, Yang Du, Xiaolian Sun and Xi Hu. Their work appears in journals such as Nano Letters, ACS Nano and Biomaterials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026